Citation Impact
Citing Papers
Upregulation of Hypoxia-Inducible Factors in Normal and Psoriatic Skin
2007
Tight Control of Hypoxia-inducible Factor-α Transient Dynamics Is Essential for Cell Survival in Hypoxia
2014
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts
2011 Nature
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
2011
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
2016 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique
2006
Cross-talk between neural stem cells and immune cells: the key to better brain repair?
2012
Diabetic retinopathy
2010 Standout
Role of erythropoietin in the brain
2007
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
2011 Standout
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion
2007 Standout
Toll-like receptors in neurodegeneration
2008
The role of melatonin as an antioxidant in the follicle
2012
Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional Neurons
2011 StandoutNobel
Nanoscale drug delivery systems and the blood–brain barrier
2014
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration
2013
Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond
2021
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use
2009
Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity
2012 StandoutNobel
Chronic treatment with melatonin stimulates dendrite maturation and complexity in adult hippocampal neurogenesis of mice
2010
Melatonin and Synthetic Melatonergic Agonists: Actions and Metabolism in the Central Nervous System
2012
Melatonin attenuates methamphetamine‐induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK‐N‐SH cells
2008
Retinopathy of prematurity
2013 Standout
Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors
2008
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats
2007
Pattern Recognition Receptors and Inflammation
2010 Standout
Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury
2011
HIF-1α in Epidermis: Oxygen Sensing, Cutaneous Angiogenesis, Cancer, and Non-Cancer Disorders
2011
Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling
2011
Hypoxic preconditioning involves system Xc− regulation in mouse neural stem cells
2011
Cerebral blood flow alteration in neuroprotection following cerebral ischaemia
2011
Identification of proteins differentially expressed by melatonin treatment in cerebral ischemic injury – a proteomics approach
2009
Age-related macular degeneration
2012 Standout
Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies
2005
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells
2013 StandoutNobel
Diabetic Retinopathy
2012 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Psoriasis
2015 Standout
Stress-Induced Neuroinflammation: Role of the Toll-Like Receptor-4 Pathway
2012
Melatonin promotes neurogenesis in dentate gyrus in the pinealectomized rat
2009
Role and Therapeutic Potential of VEGF in the Nervous System
2009
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Green tea extracts interfere with the stress‐protective activity of PrPC and the formation of PrPSc
2008
Capillary pericytes regulate cerebral blood flow in health and disease
2014 StandoutNature
Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets
2008
The immunology of stroke: from mechanisms to translation
2011 Standout
CNS Immune Responses Following Experimental Stroke
2009
Antiinflammatory Activity of Melatonin in Central Nervous System
2010
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
Emerging therapeutic approaches in the management of retinal angiogenesis and edema
2010
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY
2009
Melatonin: A Multitasking Molecule
2010
The Antioxidant Cerebralcare Granule® Attenuates Cerebral Microcirculatory Disturbance During Ischemia-Reperfusion Injury
2008
Erythropoietin deficiency decreases vascular stability in mice
2008
Müller cell‐derived VEGF is a significant contributor to retinal neovascularization
2009
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
2009
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Delivery of bioactive molecules into the cell: the Trojan horse approach
2004
The Pathobiology of Vascular Dementia
2013 Standout
Melatonin and pregnancy in the human
2008
Ferroptosis and Necroptosis in the Kidney
2020
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Induced Neuronal Cells: How to Make and Define a Neuron
2011 StandoutNobel
Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice
2012
Regulation of innate immune responses in the brain
2009
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Melatonin maintains adult hippocampal neurogenesis and cognitive functions after irradiation
2009
HIF-1alpha and HIF-2alpha Are Differentially Activated in Distinct Cell Populations in Retinal Ischaemia
2010
ATP-Binding Cassette Transporters and Their Roles in Protecting the Brain
2011
Therapeutic Manipulation of the HIF Hydroxylases
2009
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Positron Emission Tomography Imaging of Poststroke Angiogenesis
2008
Neurological Diseases in Relation to the Blood–Brain Barrier
2012
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
2010 Standout
Neuroprotection by Dimethyloxalylglycine following Permanent and Transient Focal Cerebral Ischemia in Rats
2010
Postischemic Brain Injury Is Exacerbated in Mice Lacking the Kinin B2 Receptor
2006
Clinical aspects of melatonin.
2008
Intravitreal Injection of Erythropoietin Protects both Retinal Vascular and Neuronal Cells in Early Diabetes
2008
Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
2010
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Small Molecule JNK (c-Jun N-Terminal Kinase) Inhibitors
2010
Protecting Against Cerebrovascular Injury
2008
Inflammatory Mechanisms in Obesity
2011 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Apoptotic Mechanisms After Cerebral Ischemia
2009 Standout
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
2018
VEGF Protects Brain against Focal Ischemia without Increasing Blood–Brain Permeability When Administered Intracerebroventricularly
2005
Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation
2013 StandoutNobel
Implications of ATP-binding cassette transporters for brain pharmacotherapies
2007
Erythropoietin: Powerful protection of ischemic and post-ischemic brain
2014
THE ANTIOXIDANT CEREBRALCARE GRANULE ATTENUATES CEREBRAL MICROCIRCULATORY DISTURBANCE DURING ISCHEMIA-REPERFUSION INJURY
2009
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Physiology of Microglia
2011 Standout
Melatonin signaling and cell protection function
2010
Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations
2017
Works of Ülkan Kılıç being referenced
ABCC1: a gateway for pharmacological compounds to the ischaemic brain
2008
Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia
2006
Tissue‐plasminogen activator‐induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt
2005
Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration
2005
Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2
2005
Tissue Plasminogen Activator-Induced Ischemic Injury Is Reversed by NMDA Antagonist MK-801 in vivo
2005
Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase‐3 and is suitable as an add‐on treatment to tissue‐plasminogen activator
2004
Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme‐1
2004
Evidence that membrane‐bound G protein‐coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia
2011
The TAT Protein Transduction Domain Enhances the Neuroprotective Effect of Glial-Cell-Line-Derived Neurotrophic Factor after Optic Nerve Transection
2004
Aggravation of ischemic brain injury by prion protein deficiency: Role of ERK-1/-2 and STAT-1
2005
Signal transduction pathways involved in melatonin‐induced neuroprotection after focal cerebral ischemia in mice
2004
Human Vascular Endothelial Growth Factor Protects Axotomized Retinal Ganglion CellsIn Vivoby Activating ERK-1/2 and Akt Pathways
2006
Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
2009
Poxvirus-derived cytokine response modifier A (CrmA) does not protect against focal cerebral ischemia in mice
2007
Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice
2008
TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration
2008
When Melatonin Gets on Your Nerves: Its Beneficial Actions in Experimental Models of Stroke
2005
MicroRNA 199a Is Downregulated in Patients After Coronary Artery Bypass Graft Surgery and Is Associated with Increased Levels of Sirtuin 1 (SIRT 1) Protein and Major Adverse Cardiovascular Events at 3-Year Follow-Up
2018
Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischaemia
2006
Brain-selective VEGF overexpression induces post-ischemic neuroprotection, but also facilitates hemodynamic steal phenomena
2004
Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
2005
The phosphatidylinositol‐3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia
2006
Erythropoietin protects from axotomy‐induced degeneration of retinal ganglion cells by activating ERK‐1/‐2
2004
Brain‐derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK‐1/‐2 and Akt pathways
2005
Intravenous TAT-GDNF Is Protective After Focal Cerebral Ischemia in Mice
2003
c-Jun N-Terminal Kinase 2 Deficiency Protects Against Hypercholesterolemia-Induced Endothelial Dysfunction and Oxidative Stress
2008